Dental amalgam fillings and Helicobacter pylori eradication rates: wide-ranging implications.
aAcademic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin bRoyal College of Surgeons in Ireland, Dublin 2, Ireland cUniversity of Utrecht, Utrecht, The Netherlands dUniversity of Brasília, Brasília, Brazil.
James P K
JP
Rooney
Myrthe N
MN
Frissen
Gary A
GA
Bass
Jose G
JG
Dórea
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003723:Dental Amalgam / Q000009:adverse effects*; D003793:Dental Restoration, Permanent / Q000009:adverse effects*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D064704:Levofloxacin / Q000008:administration & dosage*; D008297:Male; D014508:Urea / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D064704:Levofloxacin; D003723:Dental Amalgam; D014508:Urea